Latest News and Press Releases

Pasithea Tx' PAS-004 shows up to 91% pERK inhibition in Phase 1 trial; one pancreatic cancer patient sees 4+ months stable disease and tumor shrinkage.

Dublin, Jan. 24, 2025 (GLOBE NEWSWIRE) -- The "Biosimulation Market Report 2025" has been added to ResearchAndMarkets.com's offering.The biosimulation market size is forecast to see rapid growth in...

Dublin, Jan. 06, 2025 (GLOBE NEWSWIRE) -- The "Therapeutic Drug Monitoring Market by Product, Technology, Drug Class, Therapeutic Area, Specimen, End User - Global Forecast to 2029" report has been...

Data support favorable safety and tolerability profile with no serious adverse events (SAEs) or study-related drug discontinuationsEnrollment to be extended due to low influenza infection among...

Remedy Plan Therapeutics Initiates Dosing in Phase 1 Clinical Trial of RPT1G, a First-In-Class Hyperbolic NAMPT Inhibitor

ProductLife Group (PLG) is pleased to announce the acquisition of IntiQuan AG, a premier Swiss boutique specializing in pharmacometric services.

Dublin, Oct. 02, 2024 (GLOBE NEWSWIRE) -- The "India Therapeutic Drug Monitoring Market, By Region, Competition, Forecast and Opportunities 2020-2030F" report has been added to ...

Selbyville, Delaware, Sept. 25, 2024 (GLOBE NEWSWIRE) -- Anti-retroviral Drugs Market size will reach USD 42.5 billion by 2032. Growing awareness and early diagnosis of HIV will accelerate...

Dublin, Aug. 30, 2024 (GLOBE NEWSWIRE) -- The "Drug Discovery Services - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market for Drug...

Dublin, Aug. 30, 2024 (GLOBE NEWSWIRE) -- The "Preclinical Imaging (In-VIVO) - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market for...